SCLERO.ORG
Search
SCLERO.ORG is retiring 4-24-2021. Thank you for the memories! You'll still find us in the Wayback Machine, and we'll carry your stories in our hearts forever.

Completed: Awaiting Results

Author: Shelley Ensz. Scleroderma is highly variable. See Types of Scleroderma. Read Disclaimer

Psychological Treatments for Scleroderma

Study closed. Awaiting results.

Psychological Treatments for Scleroderma. This study will examine the effectiveness of two psychological treatment approaches designed to help people who have scleroderma with three important areas of daily living: pain, depression, and distress about changes in appearance. Study dates 2001-2004. ClinicalTrials.gov

Sildenafil (Viagra) in Treatment of Pulmonary Hypertension

Study closed. Awaiting results.

Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension. To assess the safety of sildenafil 20 mg TID orally given to Japanese pulmonary arterial hypertension patients (Part 1 and 2) To assess the efficacy after 12 weeks of treatment of sildenafil 20 mg TID orally given to Japanese pulmonary arterial hypertension patients (Part 1). March, 2009. ClinicalTrials.gov.

Also See

Sjögren's Treatments & Clinical Trials
Scleroderma Medical News

Scleroderma Symptoms (treatments are listed for each symptom)

Go to Scleroderma Clinical Trials: Inconclusive
 

SCLERO.ORG was the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses from 1998 to 2021. It was a grassroots movement from the original Scleroderma from A to Z web site, which was founded by Shelley Ensz. We were a 501(c)(3) U.S.-based public charitable foundation. We closed this web site and our nonprofit agency in April 2021.

International Scleroderma Network (ISN)